Mathematical modelling is becoming an increasingly important tool in public health, helping scientists and policymakers predict disease outbreaks, evaluate intervention strategies, and allocate healthcare resources more effectively. Speaking at a faculty development programme at Indian Institute of Technology Patna, Director T. N. Singh stressed that data-driven mathematical models are essential for understanding and controlling infectious diseases.

Predicting outbreaks and planning responses

Addressing participants at a six-day faculty development programme on "Mathematical Modelling of Diseases" under the Malaviya Mission Teacher Training Centre, Singh said mathematical models enable public health authorities to:

  • Forecast the trajectory of epidemics.
  • Estimate future healthcare demand.
  • Optimise limited resources such as vaccine stockpiles and hospital capacity.
  • Test intervention strategies virtually before implementing them in real-world settings.

Such simulations allow policymakers to assess the likely impact of measures like vaccination campaigns, lockdowns, or vector-control programmes without exposing populations to unnecessary risks.

Understanding how diseases spread

Singh explained that mathematical disease models combine multiple sources of information—including demographic, environmental and biological data—to better understand disease transmission.

He cited dengue as an example, noting that models can help researchers examine how factors such as climate change, rainfall patterns and temperature influence mosquito populations and disease spread. This enables health agencies to design more targeted prevention and surveillance strategies.

Linking modern science with India's mathematical heritage

Highlighting India's long tradition of mathematical thinking, Singh referred to ancient texts such as the Shulba Sutras and the Surya Siddhanta.

He noted that the precise calculation of the value of pi described in the Shulba Sutras and Aryabhata's geometric estimation of the distance between the Earth and the Sun illustrate the longstanding use of mathematical modelling in India.

Building interdisciplinary expertise

Programme coordinator Prashant K. Srivastava said the faculty development programme is designed to strengthen participants' analytical skills, research capabilities and understanding of mathematical disease modelling—an interdisciplinary field that brings together mathematics, epidemiology, biology, statistics and computer science.

Why mathematical modelling matters

The growing importance of mathematical modelling has been evident during recent global health emergencies, where predictive models have informed decisions on vaccination strategies, hospital preparedness and outbreak containment.

As emerging infectious diseases become increasingly influenced by factors such as climate change, urbanisation and global travel, expertise in mathematical modelling is expected to play an even larger role in supporting evidence-based public health planning and strengthening epidemic preparedness.

 

In a landmark initiative aimed at redefining healthcare leadership in India, Devi Shetty, Chairman and Founder of Narayana Health, has announced plans to establish the country's first nurse-led hospital, where nurses will take charge of operational management alongside their clinical responsibilities.

The upcoming smart, paperless hospital in Banashankari, Bengaluru, will introduce a new model of hospital governance by placing nurses at the centre of administrative decision-making, with the long-term goal of developing them into future hospital CEOs. The announcement was made through a video shared on Narayana Health's official social media platforms.

Unlike conventional hospitals, where nurses primarily focus on patient care, the new facility will enable them to oversee operational workflows, governance and management functions. The initiative seeks to recognise nurses not only as caregivers but also as leaders capable of driving healthcare institutions.

To prepare participants for these expanded responsibilities, Narayana Health will offer selected nurses a dual-benefit model. In addition to their regular clinical salary, they will receive management-linked incentives and be enrolled in an executive management programme at the Indian Institute of Management, Bangalore. The specialised training is designed to equip nurses with leadership, finance, operations and strategic management skills required to lead modern healthcare organisations.

The programme is open to nurses with one to two years of professional experience, signalling a shift from seniority-based leadership to merit, ambition and leadership potential. According to Dr Shetty, the initiative aims to create opportunities for young nursing professionals to progress from bedside caregiving to boardroom leadership.

The announcement comes at a time when healthcare systems worldwide are increasingly recognising the critical role of nurses in improving patient outcomes, hospital efficiency and healthcare innovation. By combining clinical expertise with executive education, the initiative could redefine career pathways in India's nursing profession and strengthen leadership diversity within the healthcare sector.

If successful, the nurse-led hospital model could inspire similar reforms across hospitals in India, creating new opportunities for nursing professionals while demonstrating that healthcare leadership can extend well beyond the doctor's office to those who are often at the heart of patient care.

 

Mankind Pharma, AI drug discovery, Denovo Sciences, artificial intelligence in healthcare, pharmaceutical innovation, and drug research are in focus after Mankind Pharma announced a strategic partnership with Denovo Sciences to develop an artificial intelligence-led drug discovery programme. The collaboration aims to accelerate early-stage research, improve the quality of drug candidates, and bring innovative therapies to patients more efficiently.

Under the partnership, Mankind Pharma will combine its research, experimental and clinical development capabilities with Denovo Sciences' proprietary AI platform for molecular generation and prioritisation. The companies aim to shorten drug discovery timelines by identifying the most promising molecular candidates at an early stage, enabling researchers to focus resources on compounds with higher potential for success.

A key feature of the collaboration is its human-in-the-loop approach, which integrates artificial intelligence with scientific expertise. While AI systems will generate, analyse and rank potential drug molecules using computational models, experienced researchers will validate, refine and guide the selection process throughout the discovery cycle. The companies believe this hybrid model will combine the speed and scale of AI with the critical judgement of scientists, improving decision-making and reducing the likelihood of advancing unsuitable candidates.

The partnership reflects the pharmaceutical industry's growing adoption of artificial intelligence to improve research productivity and reduce the time and cost associated with developing new medicines. By using AI to explore vast molecular datasets and identify promising compounds more efficiently, pharmaceutical companies hope to accelerate innovation while lowering the risks traditionally associated with early-stage drug development.

Mankind Pharma said the collaboration aligns with its long-term strategy of strengthening technology-driven research and development capabilities. The company believes integrating AI into its discovery pipeline will help create differentiated therapies while improving access to effective treatments for patients.

Denovo Sciences also described the collaboration as an opportunity to maximise the impact of artificial intelligence during the earliest stages of drug development, where better candidate selection can significantly reduce research costs and improve success rates.

Industry experts view the alliance as part of a broader shift toward AI-enabled pharmaceutical research. If successful, the partnership could accelerate the development of novel drug candidates for clinical trials and strengthen Mankind Pharma's position in India's innovation-driven pharmaceutical sector while enhancing its competitiveness in global healthcare markets.

 

In a significant development for healthcare professionals seeking careers beyond traditional clinical practice, Academically Global has announced 100% placement for the inaugural batch of its executive programmes in Clinical Drug Development and Medical Affairs & Medical Science Liaison.

According to the organisation, every participant in the four-month programme secured employment in high-demand non-clinical healthcare roles, highlighting the growing demand for professionals with clinical knowledge in the pharmaceutical, biotechnology and healthcare industries.

Graduates Placed Across High-Growth Healthcare Sectors

The first batch of participants has reportedly been placed in a range of specialised roles, including:

  • Pharmacovigilance
  • Drug safety
  • Medical affairs
  • Clinical research
  • Regulatory affairs
  • Medical writing

The organisation stated that annual salary packages ranged from ₹8 lakh to ₹32 lakh, depending on candidates' qualifications, experience and job profiles.

Addressing a Growing Skills Gap

Despite ongoing discussions about shortages of healthcare professionals in India, many graduates from MBBS, BDS, PharmD and AYUSH programmes continue to face limited career progression and intense competition for clinical positions.

According to Dr. Akram Ahmad, the challenge often lies not in academic qualifications but in limited awareness of emerging career opportunities and the lack of industry-specific skills required for non-clinical roles.

The executive programmes were designed to bridge this gap by equipping healthcare graduates with specialised knowledge relevant to pharmaceutical companies, contract research organisations (CROs), medical communications firms and regulatory agencies.

Expanding Career Options Beyond Clinical Practice

The success of the placement drive reflects the growing scope of non-clinical careers within the healthcare ecosystem.

Industry demand continues to rise in areas such as:

  • Pharmacovigilance
  • Medical science liaison
  • Clinical trial management
  • Regulatory compliance
  • Medical communications
  • Drug development
  • Healthcare consulting

In addition to these specialised fields, healthcare experts also point to expanding opportunities in allied disciplines including physiotherapy, nursing, radiology, laboratory technology, hospital administration, biotechnology, nutrition, genetics, bioinformatics and clinical psychology.

Global Academic Collaboration

The programmes received academic support from international experts, reinforcing their focus on industry relevance.

The inaugural session was launched by Rajesh Balkrishnan, while certificates were presented by Zaheer-Ud-Din Babar at the programme's conclusion.

According to the organisation, both academics contributed to curriculum development and emphasised the importance of aligning healthcare education with evolving global workforce requirements.

From International Licensing to Domestic Workforce Development

Founded in 2022, Academically Global initially focused on preparing healthcare professionals for international licensing examinations and overseas career opportunities.

After supporting more than 10,000 healthcare graduates pursuing global pathways, the organisation identified increasing domestic demand for professionals trained in non-clinical healthcare functions.

This led to the launch of intensive executive programmes combining industry-oriented training, mentorship and placement assistance through its recruitment platform.

A Growing Trend in Healthcare Employment

The reported 100% placement outcome highlights the increasing importance of non-clinical healthcare roles in India's expanding pharmaceutical and life sciences sectors.

As healthcare technology, drug development, regulatory science and clinical research continue to grow, professionals with medical and allied health backgrounds are finding opportunities beyond hospitals and direct patient care.

However, experts note that sustaining such outcomes will depend on continued industry demand, regular curriculum updates and close collaboration between academic institutions and employers to ensure graduates remain equipped with skills relevant to a rapidly evolving healthcare landscape.

 

In a significant move to strengthen traditional medical education, the Uttar Pradesh government is planning to establish specialised Ayurveda gurukuls that will allow students to begin their journey towards becoming Ayurvedic doctors immediately after completing their Class 10 board examinations.

The proposed initiative seeks to revive the ancient gurukul system while integrating it with modern medical education, creating a unique pathway that culminates in a Bachelor of Ayurvedic Medicine and Surgery (BAMS) degree.

Integrated Pathway from Class 10 to BAMS

Under the proposed model, five Ayurveda gurukuls will be established across the state, each offering 100 BAMS seats.

Admission will be based on an entrance examination conducted after Class 10. Selected students will complete their higher secondary education alongside specialised Ayurveda training before progressing into the integrated BAMS programme.

Officials say the initiative is aimed at nurturing students at an earlier stage, allowing them to build a deeper understanding of Ayurveda throughout their academic journey.

Ancient Gurukul Tradition Meets Modern Medical Education

The proposed institutions will closely follow the traditional residential gurukul system of ancient India, where students (shishyas) live and learn under the guidance of their teachers (gurus).

According to Uttar Pradesh Principal Secretary (AYUSH) Ranjan Kumar, the objective is to produce practitioners who understand Ayurveda from its foundational principles, including classical Sanskrit texts that form the basis of the traditional medical system.

The curriculum will combine:

  • Traditional Ayurvedic knowledge and Sanskrit learning
  • Modern medical education leading to a BAMS degree
  • Hands-on clinical training
  • Holistic wellness and healing practices
  • Ethical values and disciplined residential learning

The government believes this comprehensive approach will prepare graduates who are proficient in both traditional Ayurvedic philosophy and contemporary healthcare practices.

Focus on Holistic Learning

Unlike conventional medical education, the proposed gurukuls will emphasise holistic development alongside academic excellence.

Students from diverse social and economic backgrounds will live together on campus, sharing daily responsibilities and participating in community-based activities designed to promote equality, discipline and character building.

Officials say the institutions aim to produce well-rounded practitioners who understand not only Ayurvedic medicine but also India's long-standing traditions of preventive healthcare and wellness.

Cabinet Approval Awaited

The proposal is expected to be placed before the Uttar Pradesh Cabinet for approval. Once cleared, the state government will begin identifying land for the first five gurukuls and initiate the process of designing the academic curriculum.

If the pilot project proves successful, the government plans to establish additional Ayurveda gurukuls across the state in the coming years.

Boosting India's Traditional Healthcare Ecosystem

The initiative aligns with the broader objective of promoting India's traditional systems of medicine under the AYUSH framework. By introducing students to Ayurveda immediately after secondary school, the Uttar Pradesh government hopes to create a new generation of practitioners with a stronger grounding in classical knowledge, clinical practice and holistic healthcare.

If implemented, the programme could become one of India's first large-scale attempts to blend the centuries-old gurukul model with structured medical education, potentially reshaping the future of Ayurveda training in the country.

 

The All India Institute of Medical Sciences (AIIMS), New Delhi has introduced a comprehensive social media policy that prohibits students, faculty, staff and affiliated bodies from using the institute's name, logo, emblem or branding on social media platforms and promotional material without prior written approval.

The new guidelines are aimed at regulating the use of AIIMS' institutional identity across digital platforms while ensuring that official communication remains accurate, responsible and aligned with the institute's values.

Who will be covered by the new AIIMS policy?

The social media policy applies to:

  • Undergraduate, postgraduate, doctoral and super-speciality students.
  • Student associations, societies and recognised bodies such as ASA, RDA and SYS.
  • Faculty members, researchers and administrative staff communicating on behalf of AIIMS.
  • Departments, centres and institutional bodies operating official or semi-official digital platforms.
  • Third-party collaborators and individuals granted temporary access to AIIMS communication channels.

Approval mandatory before using AIIMS branding

Under the revised guidelines, no individual or organisation associated with AIIMS can use the institute's name, logo, emblem or official branding in digital or print formats without obtaining prior written permission from the concerned department.

The restriction covers a wide range of communication materials, including:

  • Social media accounts on platforms such as Instagram, Facebook and X.
  • Event posters, banners and promotional creatives.
  • Videos, reels, podcasts and blogs carrying AIIMS branding.
  • Publicity material prepared for institutional events or collaborations.

New registration and content approval process

Student organisations and departments operating official social media accounts must now comply with additional administrative requirements.

They will be required to:

  • Register official social media accounts with the concerned department.
  • Submit the names, contact details and institutional email IDs of account administrators.
  • Appoint a designated Media Coordinator responsible for content approval.
  • Clearly state whether content is student-generated or department-generated unless officially endorsed by AIIMS.

The institute has also instructed users to avoid posting confidential institutional information, politically sensitive or religious content, defamatory material, or any communication that could harm the institute's reputation.

Sponsored posts, promotional collaborations and partnerships with external brands will require separate institutional approval.

AIIMS warns of disciplinary and legal action

The institute has warned that misuse of its name, logo or institutional identity, or violations of the new social media policy, may invite both disciplinary and legal consequences.

Possible disciplinary measures include:

  • Written warnings.
  • Suspension of institutional privileges or association.
  • Derecognition of student organisations or societies.
  • Restriction or denial of permission to organise institutional events.
  • Legal action in cases involving unauthorised use of AIIMS branding or serious policy violations.

Why the new policy matters

The latest guidelines reflect a growing trend among higher educational institutions to strengthen governance over their digital identity as social media becomes an increasingly influential communication platform.

By introducing a structured approval process, AIIMS aims to prevent unauthorised use of its brand, reduce the risk of misinformation, and ensure that official communication maintains professional standards while protecting the institute's reputation.

The National Eligibility-cum-Entrance Test (NEET-UG) 2026 re-examination was conducted smoothly across Noida, Greater Noida and Ghaziabad on Sunday, with more than 18,000 medical aspirants appearing for the high-stakes entrance examination under extensive security arrangements.

The re-examination, organised by the National Testing Agency (NTA), follows the cancellation of the original NEET-UG exam due to allegations of a question paper leak. The retest is a crucial step in restoring confidence in India's medical entrance examination system and ensuring a fair opportunity for lakhs of aspiring doctors.

According to examination authorities, Gautam Budh Nagar district recorded an attendance rate of over 88 per cent. Of the 10,823 candidates registered across 23 examination centres, 9,540 students appeared for the test. In neighbouring Ghaziabad, 8,743 of the 9,666 registered candidates attended the examination at 22 centres, resulting in an attendance rate of approximately 90.4 per cent.

To ensure the secure conduct of the examination, more than 1,000 police personnel were deployed across examination venues and major traffic points. Authorities established help desks near metro stations, bus stands and transit hubs to assist students and parents travelling to centres.

Security measures included CCTV surveillance, frisking of candidates, regulated entry and exit procedures, parking management and continuous monitoring of traffic movement around examination venues. Senior police officials supervised arrangements throughout the day to ensure a smooth and transparent examination process.

The examination was conducted from 2:30 pm to 5:30 pm, while candidates with benchmark disabilities were provided additional time in accordance with prescribed guidelines.

Many students expressed relief after finally being able to appear for the examination following weeks of uncertainty. Candidates said the prolonged delay caused anxiety and disrupted preparation schedules, but they remained hopeful that the re-examination would conclude the controversy surrounding the test.

Education experts noted that maintaining transparency, security and student welfare is critical for safeguarding the credibility of national-level entrance examinations.

More Articles ...